BD Welcomes Bilal Muhsin as Executive Vice President
BD (Becton, Dickinson and Company) (NYSE: BDX), a prominent global healthcare technology leader, has appointed Bilal Muhsin as the Executive Vice President and President of the newly established Future Connected Care segment. This strategic move is part of BD's commitment to advancing its innovative New BD strategy.
Significance of the Appointment
Effective immediately, Bilal will be integral in developing BD's Connected Care strategy, focusing on advanced analytics and AI solutions paired with state-of-the-art smart devices. His leadership will help streamline patient care processes and uncover new growth opportunities in healthcare sectors such as connected medication management and smart monitoring solutions.
Responsibilities Under the New Role
In this vital role, Bilal Muhsin will oversee the advancement of BD's Connected Care strategy—this entails refining organizational capabilities, executing commercial strategies, and spearheading innovative initiatives while ensuring excellence in operations and quality.
Expertise and Background
Bilal's extensive experience brings a wealth of knowledge in connected care technologies and software strategies. Having previously worked at Masimo for over 25 years, where his final position was Chief Operating Officer, he possesses a robust understanding and track record in medical engineering and software development. He has contributed over 50 patents related to Medical Systems Communication and Analytics, underscoring his innovative capabilities.
Transforming Healthcare with Innovation
BD is dedicated to enhancing patient safety and outcomes. With the deep focus on customer-centric technology, Bilal's appointment is poised to significantly impact BD's mission of delivering superior care through AI-driven advancements. Tom Polen, BD's Chairman and CEO, remarked on the positive influence Bilal will have on the company's trajectory in transforming patient care with innovative technology.
About BD
BD stands as one of the largest medical technology companies globally, committed to advancing the world of health by improving medical discovery, diagnostics, and delivery of care. With over 70,000 employees, BD is deeply invested in enhancing the efficiency of healthcare providers and supporting laboratory scientists to accurately detect diseases. The company collaborates worldwide to tackle challenging health issues, striving to improve outcomes, reduce costs, and expand healthcare access.
Frequently Asked Questions
Who is Bilal Muhsin?
Bilal Muhsin is the newly appointed Executive Vice President and President of BD's Future Connected Care segment, with extensive experience in connected care technology.
What is the Future Connected Care segment?
The Future Connected Care segment at BD focuses on integrating advanced analytics and AI with smart medical devices to improve patient care.
What was Bilal's role prior to BD?
Before joining BD, Bilal Muhsin served as Chief Operating Officer at Masimo, with a solid background in engineering, marketing, and regulatory roles.
What is BD's mission?
BD aims to advance health by improving medical discovery, diagnostics, and the delivery of care through innovative technology and services.
How does BD plan to innovate in healthcare?
BD plans to leverage AI-driven technology and smart devices to enhance patient safety, operational excellence, and healthcare outcomes.
